Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Literature
1.
Amarnath AL, Franks P, Robbins JA, Xing G, Fenton JJ. Underuse and overuse of osteoporosis screening in a regional health system: a retrospective cohort study. J. Gen. Intern. Med. 2015; doi:10.​1007/​s11606-015-3349-8.
2.
Chow SL, Thorne C, Bell MJ, Ferrari R, Bagheri Z, Boyd T, et al. Choosing wisely Canada. Canadian Rheumatology Association: five things physicians and patients should question. J. Rheumatol. 2015; doi: 10.​3899/​jrheum.​141140.
3.
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182:1864–73.PubMedCentralCrossRefPubMed
4.
Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA. 2007;298:629–37.CrossRefPubMed
5.
Ferrari R. Prevalence of osteoporosis in men aged 65–75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening. Clin. Rheumatol. 2014.
Metadata
Title
Re: Underuse and Overuse of Osteoporosis Screening in a Regional Health System: A Retrospective Cohort Study
Author
Robert Ferrari, M.D., M.Sc. (Med)., F.R.C.P.C., F.A.C.P.
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3451-y

Other articles of this Issue 2/2016

Journal of General Internal Medicine 2/2016 Go to the issue

Health Policy

The Roles of Cost and Quality Information in Medicare Advantage Plan Enrollment Decisions: an Observational Study

Editorial

Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions

OriginalPaper

Variation among Primary Care Physicians in the Use of Imaging for Older Patients with Acute Low Back Pain

Editorial

The Veterans Choice Act and Dual Health System Use

Original Research

Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients

Capsule Commentary

Capsule Commentary on Peltz-Sinvani et al., Low ALT Levels Independently Associated with 22-Year All-Cause Mortality among Coronary Heart Disease Patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits